Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Amarin Corp Plc (NQ: AMRN)
7.070 USD  +0.090 (+1.29%)
Streaming Delayed Price  /  Updated: 11:06 AM EDT, May 22, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Amarin Corp Plc
 
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Critical Alerts for Coca-Cola, Harley Davidson, GameStop, Riverbed Technology, and Amarin Released by Seven Summits Research
March 02, 2012
from PR Newswire
Research Reports for Penny Stock Top Movers: Liz Claiborne, Amarin, Spreadtrum Communications, First Niagara Financial, and Vocus
March 01, 2012
from PR Newswire
Amarin Reports Fourth Quarter and Year-End 2011 Financial Results and Provides Update on Operations
February 29, 2012
Conference Call Set for 4:30 p.m. EST Today Read More
from GlobeNewswire News Releases
Amarin to Report Fourth Quarter and Year-End 2011 Results and Host Conference Call on February 29, 2012
February 22, 2012
Conference Call Set for 4:30 p.m. EST on Feb. 29 Read More
from GlobeNewswire News Releases
Amarin to Present at the CITI 2012 Global Healthcare Conference
February 22, 2012
from GlobeNewswire News Releases
Amarin Corporation Appoints Dr. Steven Ketchum to Head Research and Development and Announces Inducement Grant Under NASDAQ Rule 5635(c)(4)
February 16, 2012
from GlobeNewswire News Releases
Amarin Announces FDA Advisory Committee Will Not Be Scheduled in Connection With New Drug Application for AMR101
February 13, 2012
from GlobeNewswire News Releases
Amarin to Present at the Leerink Swann 2012 Global Healthcare Conference
February 07, 2012
from GlobeNewswire News Releases
A Forward Look, the Year Ahead - Featured Research on Amarin Corporation plc (ADR) and GlaxoSmithKline plc (ADR)
February 06, 2012
from Marketwired News Releases
2012 Economic Outlook - Report Highlights Petroleo Brasileiro SA (ADR) and Amarin Corporation plc (ADR)
February 02, 2012
from Marketwired News Releases
Research Reports on Top Traded Stocks: Genworth Financial, Suntech Power Holdings, Human Genome Sciences, Sirius, Amarin and Hercules Offshore
January 20, 2012
from PR Newswire
Amarin Corporation plc Announces Pricing of $150 Million of Exchangeable Senior Notes Due 2032
January 04, 2012
from GlobeNewswire News Releases
Amarin Corporation plc Announces Offering of $150 Million of Exchangeable Senior Notes Due 2032
January 03, 2012
from GlobeNewswire News Releases
Amarin Commences 2012 With Letter to Shareholders
January 03, 2012
2012 Priorities Outlined Read More
from GlobeNewswire News Releases
Amarin Announces Appointment of Joseph T. Kennedy as General Counsel and Issuance of Inducement Grant Under NASDAQ Rule 5635(c)(4)
December 19, 2011
from GlobeNewswire News Releases
Amarin Announces the Addition of Industry Veteran Patrick O'Sullivan to Board
December 14, 2011
from GlobeNewswire News Releases
Amarin Announces Dosing of First Patient in Cardiovascular Outcomes Study REDUCE-IT
December 07, 2011
Study Will Evaluate the Effectiveness of AMR101 in Reducing Major Cardiovascular Events in a High-Risk Patient Population Read More
from GlobeNewswire News Releases
Amarin Announces FDA Acceptance for Filing of AMR101 NDA
November 25, 2011
from GlobeNewswire News Releases
Amarin Announces Resignation of David Feigal from Board of Directors
November 25, 2011
from GlobeNewswire News Releases
Amarin Added to NASDAQ Biotechnology Index
November 21, 2011
from GlobeNewswire News Releases
Volatile Nature of Biotechnology Industry Weighs on Amarin Corporation and Alimera Sciences
November 16, 2011
The Paragon Report Provides Equity Research on Amarin Corporation & Alimera Sciences Read More
from Marketwired News Releases
Amarin's Phase 3 ANCHOR Study Results Presented at American Heart Association's Scientific Sessions 2011
November 16, 2011
Amarin's AMR101 Significantly Reduced Triglyceride Levels and Other Lipid Parameters in Statin-Treated Patients With Persistent High Triglycerides Read More
from GlobeNewswire News Releases
Amarin's Phase 3 MARINE Study Results Presented at American Heart Association's Scientific Sessions 2011
November 15, 2011
Lipoprotein Particle Concentration Considered an Important Factor Influencing Atherogenicity Read More
from GlobeNewswire News Releases
Amarin's Phase 3 MARINE and ANCHOR Study Data to be Presented at American Heart Association's Scientific Sessions 2011
November 14, 2011
from GlobeNewswire News Releases
Amarin to Present at Two Upcoming Investor Conferences
November 10, 2011
from GlobeNewswire News Releases
Amarin Reports Third Quarter 2011 Results
November 07, 2011
Conference Call Set for 8:00 am EST November 8 Read More
from GlobeNewswire News Releases
Amarin Announces Q3, 2011 Results Conference Call
November 03, 2011
Conference Call Set for 8:00 am ET, November 8 Read More
from GlobeNewswire News Releases
Amarin to Ring NASDAQ Closing Bell
October 31, 2011
Scheduled for Wednesday, November 2 Read More
from GlobeNewswire News Releases
Amarin Announces NDA Submission for AMR101 for the Treatment of Patients With Very High Triglycerides
September 26, 2011
from GlobeNewswire News Releases
Amarin to Present at the UBS Global Life Sciences Conference
September 19, 2011
from GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here